Pathogenic Role of LncRNA-MALAT1 in Endothelial Cell Dysfunction in Diabetes Mellitus

Overview

Journal Cell Death Dis

Specialties Cell Biology
General Medicine

Date 2014 Oct 31

PMID 25356875

Citations 223

Authors

J-Y Liu

J Yao

X-M Li

Y-C Song

X-Q Wang

Y-J Li

B Yan

Q Jiang

Affiliations

Soon will be listed here.

Abstract

Long noncoding RNAs (lncRNAs) have important roles in diverse biological processes. Our previous study has revealed that lncRNA-MALAT1 deregulation is implicated in the pathogenesis of diabetes-related microvascular disease, diabetic retinopathy (DR). However, the role of MALAT1 in retinal vasculature remodeling still remains elusive. Here we show that MALAT1 expression is significantly upregulated in the retinas of STZ-induced diabetic rats and db/db mice. MALAT1 knockdown could obviously ameliorate DR in vivo, as shown by pericyte loss, capillary degeneration, microvascular leakage, and retinal inflammation. Moreover, MALAT1 knockdown could regulate retinal endothelial cell proliferation, migration, and tube formation in vitro. The crosstalk between MALAT1 and p38 MAPK signaling pathway is involved in the regulation of endothelial cell function. MALAT1 upregulation represents a critical pathogenic mechanism for diabetes-induced microvascular dysfunction. Inhibition of MALAT1 may serve as a potential target for anti-angiogenic therapy for diabetes-related microvascular complications.

Citing Articles

Li L, Wu Y, Yang J Int J Mol Sci. 2025; 26(5).

PMID: 40076814 PMC: 11900361. DOI: 10.3390/ijms26052194.

Pathogenetic therapeutic approaches for endocrine diseases based on antisense oligonucleotides and RNA-interference.

Golounina O, Minniakhmetov I, Salakhov R, Khusainova R, Zakharova E, Bychkov I Front Endocrinol (Lausanne). 2025; 16:1525373.

PMID: 39944202 PMC: 11813780. DOI: 10.3389/fendo.2025.1525373.

Sequential changes in expression of long non-coding RNAs THRIL and MALAT1 after ischemic stroke.

Bayat M, Hooshmandi E, Karimi N, Rahimi M, Tabrizi R, Asadabadi T Curr J Neurol. 2024; 23(1):74-82.

PMID: 39431230 PMC: 11489629. DOI: 10.18502/cjn.v23i1.16437.

Role of Circulating Biomarkers in Diabetic Cardiomyopathy.

Ianos R, Cozma A, Lucaciu R, Hangan A, Negrean V, Mercea D Biomedicines. 2024; 12(9).

PMID: 39335666 PMC: 11428922. DOI: 10.3390/biomedicines12092153.

Biological functions and affected signaling pathways by Long Non-Coding RNAs in the immune system.

Ghahramani Almanghadim H, Karimi B, Valizadeh S, Ghaedi K Noncoding RNA Res. 2024; 10:70-90.

PMID: 39315339 PMC: 11417496. DOI: 10.1016/j.ncrna.2024.09.001.

References

Bell R, Long X, Lin M, Bergmann J, Nanda V, Cowan S . Identification and initial functional characterization of a human vascular cell-enriched long noncoding RNA. Arterioscler Thromb Vasc Biol. 2014; 34(6):1249-59. PMC: 4024079. DOI: 10.1161/ATVBAHA.114.303240. View

Morita H, Nagai R . Retinopathy progression in type 2 diabetes. N Engl J Med. 2010; 363(22):2171. DOI: 10.1056/NEJMc1009236. View

Hammes H, Feng Y, Pfister F, Brownlee M . Diabetic retinopathy: targeting vasoregression. Diabetes. 2011; 60(1):9-16. PMC: 3012202. DOI: 10.2337/db10-0454. View

Barber A, Gardner T, Abcouwer S . The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy. Invest Ophthalmol Vis Sci. 2011; 52(2):1156-63. PMC: 3053099. DOI: 10.1167/iovs.10-6293. View

Wapinski O, Chang H . Long noncoding RNAs and human disease. Trends Cell Biol. 2011; 21(6):354-61. DOI: 10.1016/j.tcb.2011.04.001. View

Tang J, Kern T . Inflammation in diabetic retinopathy. Prog Retin Eye Res. 2011; 30(5):343-58. PMC: 3433044. DOI: 10.1016/j.preteyeres.2011.05.002. View

Congrains A, Kamide K, Katsuya T, Yasuda O, Oguro R, Yamamoto K . CVD-associated non-coding RNA, ANRIL, modulates expression of atherogenic pathways in VSMC. Biochem Biophys Res Commun. 2012; 419(4):612-6. DOI: 10.1016/j.bbrc.2012.02.050. View

Kyriakis J, Avruch J . Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update. Physiol Rev. 2012; 92(2):689-737. DOI: 10.1152/physrev.00028.2011. View

Moran I, Akerman I, van de Bunt M, Xie R, Benazra M, Nammo T . Human β cell transcriptome analysis uncovers lncRNAs that are tissue-specific, dynamically regulated, and abnormally expressed in type 2 diabetes. Cell Metab. 2012; 16(4):435-48. PMC: 3475176. DOI: 10.1016/j.cmet.2012.08.010. View

10.

Lorenzen J, Kumarswamy R, Dangwal S, Thum T . MicroRNAs in diabetes and diabetes-associated complications. RNA Biol. 2012; 9(6):820-7. DOI: 10.4161/rna.20162. View

11.

Qiu M, Hu J, Yin R, Xu L . Long noncoding RNA: an emerging paradigm of cancer research. Tumour Biol. 2013; 34(2):613-20. DOI: 10.1007/s13277-013-0658-6. View

12.

Gutschner T, Hammerle M, Diederichs S . MALAT1 -- a paradigm for long noncoding RNA function in cancer. J Mol Med (Berl). 2013; 91(7):791-801. DOI: 10.1007/s00109-013-1028-y. View

13.

Leung A, Trac C, Jin W, Lanting L, Akbany A, Saetrom P . Novel long noncoding RNAs are regulated by angiotensin II in vascular smooth muscle cells. Circ Res. 2013; 113(3):266-78. PMC: 3763837. DOI: 10.1161/CIRCRESAHA.112.300849. View

14.

Xu X, Li K, Li X, Yao J, Qin J, Yan B . Long non-coding RNAs: new players in ocular neovascularization. Mol Biol Rep. 2014; 41(7):4493-505. DOI: 10.1007/s11033-014-3320-5. View

15.

Mercer T, Dinger M, Mattick J . Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009; 10(3):155-9. DOI: 10.1038/nrg2521. View

16.

Nguyen T, Wang J, Wong T . Retinal vascular changes in pre-diabetes and prehypertension: new findings and their research and clinical implications. Diabetes Care. 2007; 30(10):2708-15. DOI: 10.2337/dc07-0732. View

17.

Michalik K, You X, Manavski Y, Doddaballapur A, Zornig M, Braun T . Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth. Circ Res. 2014; 114(9):1389-97. DOI: 10.1161/CIRCRESAHA.114.303265. View

18.

Yan B, Tao Z, Li X, Zhang H, Yao J, Jiang Q . Aberrant expression of long noncoding RNAs in early diabetic retinopathy. Invest Ophthalmol Vis Sci. 2014; 55(2):941-51. DOI: 10.1167/iovs.13-13221. View

19.

Hu Y, Chen Y, Ding L, He X, Takahashi Y, Gao Y . Pathogenic role of diabetes-induced PPAR-α down-regulation in microvascular dysfunction. Proc Natl Acad Sci U S A. 2013; 110(38):15401-6. PMC: 3780907. DOI: 10.1073/pnas.1307211110. View

20.

Xin X, Rodrigues M, Umapathi M, Kashiwabuchi F, Ma T, Babapoor-Farrokhran S . Hypoxic retinal Muller cells promote vascular permeability by HIF-1-dependent up-regulation of angiopoietin-like 4. Proc Natl Acad Sci U S A. 2013; 110(36):E3425-34. PMC: 3767527. DOI: 10.1073/pnas.1217091110. View